FDA Inspection 1018296 — Suzanne Groah, MD
The FDA completed an inspection of Suzanne Groah, MD on April 4, 2017 in Washington, DC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 4, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Washington, DC (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7552 | 21 CFR 312.66 | Changes in research |
| 7632 | 21 CFR 312.6(a) | Required label statement |